Malignancy is a common cause of disseminated intravascular coagulation and usually presents as a chronic disorder in solid organ tumours. We present a rare case of recurrent acute disseminated intravascular coagulation in neuroendocrine carcinoma after manipulation, firstly, by core biopsy and, later, by cytotoxic therapy causing a release of procoagulants and cytokines from lysed tumour cells. This is reminiscent of tumour lysis syndrome where massive quantities of intracellular electrolytes and nucleic acid are released, causing acute metabolic imbalance and renal failure. This case highlights the potential complication of acute disseminated intravascular coagulation after trauma to malignant cells
Background: Disseminated intravascular coagulation (DIC), a systemic activation of coagulation, pres...
Disseminated intravascular coagulation (DIC) with excessive fibrinolysis (XFL) is a rare and acute l...
Background: Cancer is the second leading cause of mortality after cardiovascular disease. The second...
Disseminated Intravascular Coagulation (DIC) is a disorder of coagulation which is commonly seen as ...
The association between cancer and thrombosis is known for years. Besides the well-recognized connec...
Disseminated intravascular coagulation (DIC) is a hemor-rhagic disorder that can occur as a complica...
coagulation in cancer Disseminated intravascular coagula-tion (DIC) is a syndrome that maycomplicate...
BACKGROUND: Disseminated Intravascular Coagulation (DIC) complicates up to 7% of malignancies, the c...
A 70-year-old male presented with hematuria and bruising of arms and legs for the last three days. H...
Disseminated intravascular coagulation (DIC) is a rare, potentially life-threatening complication of...
A systemic activation of blood coagulation is usually present in many clinical conditions including ...
Disseminated intravascular coagulation (DIC) is a syndrome characterised by simultaneous bleeding an...
Two cases of acute tumor lysis syndrome occurring in patients with hepatocellular carcinoma are repo...
Background Disseminated intravascular coagulation (DIC), a systemic activation of coagulation, prese...
Copyright © 2015 Shawn Y. Ong et al. This is an open access article distributed under the Creative C...
Background: Disseminated intravascular coagulation (DIC), a systemic activation of coagulation, pres...
Disseminated intravascular coagulation (DIC) with excessive fibrinolysis (XFL) is a rare and acute l...
Background: Cancer is the second leading cause of mortality after cardiovascular disease. The second...
Disseminated Intravascular Coagulation (DIC) is a disorder of coagulation which is commonly seen as ...
The association between cancer and thrombosis is known for years. Besides the well-recognized connec...
Disseminated intravascular coagulation (DIC) is a hemor-rhagic disorder that can occur as a complica...
coagulation in cancer Disseminated intravascular coagula-tion (DIC) is a syndrome that maycomplicate...
BACKGROUND: Disseminated Intravascular Coagulation (DIC) complicates up to 7% of malignancies, the c...
A 70-year-old male presented with hematuria and bruising of arms and legs for the last three days. H...
Disseminated intravascular coagulation (DIC) is a rare, potentially life-threatening complication of...
A systemic activation of blood coagulation is usually present in many clinical conditions including ...
Disseminated intravascular coagulation (DIC) is a syndrome characterised by simultaneous bleeding an...
Two cases of acute tumor lysis syndrome occurring in patients with hepatocellular carcinoma are repo...
Background Disseminated intravascular coagulation (DIC), a systemic activation of coagulation, prese...
Copyright © 2015 Shawn Y. Ong et al. This is an open access article distributed under the Creative C...
Background: Disseminated intravascular coagulation (DIC), a systemic activation of coagulation, pres...
Disseminated intravascular coagulation (DIC) with excessive fibrinolysis (XFL) is a rare and acute l...
Background: Cancer is the second leading cause of mortality after cardiovascular disease. The second...